Patent · US Active

Sterol glucoside toxins

US8497123B2 · kind B2 · utility

1Cited by
9References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 2012
Grant dateJul 30, 2013
Priority date
Expiry dateMar 30, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/143333
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitostrol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.